{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T02:23:35Z","timestamp":1791426215098,"version":"4.3.3"},"reference-count":45,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Rheumatology"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.berh.2020.101514","type":"journal-article","created":{"date-parts":[[2020,4,23]],"date-time":"2020-04-23T17:34:23Z","timestamp":1587663263000},"page":"101514","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Primary hyperparathyroidism"],"prefix":"10.1016","volume":"34","author":[{"given":"J\u00falia V.","family":"Oberger Marques","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina A.","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.berh.2020.101514_bib1","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0140-6736(17)31430-7","article-title":"Hyperparathyroidism","volume":"391","author":"Bilezikian","year":"2018","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.berh.2020.101514_bib2","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nrendo.2017.104","article-title":"Primary hyperparathyroidism","volume":"14","author":"Walker","year":"2018","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"10.1016\/j.berh.2020.101514_bib3","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1359\/JBMR.050910","article-title":"1993 \u2013 2001\u00a0: an update on the changing epidemiology of the disease","volume":"21","author":"Wermers","year":"2006","journal-title":"J Bone Miner Res"},{"issue":"12","key":"10.1016\/j.berh.2020.101514_bib4","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1007\/s10067-016-3450-3","article-title":"Musculoskeletal manifestations of primary hyperparathyroidism","volume":"35","author":"Pappu","year":"2016","journal-title":"Clin Rheumatol"},{"issue":"2","key":"10.1016\/j.berh.2020.101514_bib5","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s11926-002-0014-0","article-title":"Rheumatic manifestations of primary hyperparathyroidism and parathyroid hormone therapy","volume":"4","author":"Rubin","year":"2002","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.berh.2020.101514_bib6","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1056\/NEJMcp1714213","article-title":"Primary hyperparathyroidism","volume":"379","author":"Insogna","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.berh.2020.101514_bib7","series-title":"Primer on the metabolic bone diseases and disorders of mineral metabolism","first-page":"104","year":"2019"},{"issue":"6","key":"10.1016\/j.berh.2020.101514_bib8","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.surg.2013.06.051","article-title":"The prevalence of undiagnosed and unrecognized primary hyperparathyroidism: a population-based analysis from the electronic medical record","volume":"154","author":"Press","year":"2013","journal-title":"Surgery"},{"key":"10.1016\/j.berh.2020.101514_bib9","first-page":"3570","volume":"99","author":"Eastell","year":"2014"},{"key":"10.1016\/j.berh.2020.101514_bib10","doi-asserted-by":"crossref","first-page":"69","DOI":"10.4137\/CMED.S13147","article-title":"Epidemiology of primary hyperparathyroidism and its non-classical manifestations in the city of recife, Brazil","volume":"6","author":"Eufrazino","year":"2013","journal-title":"Clin Med Insights Endocrinol Diabetes"},{"key":"10.1016\/j.berh.2020.101514_bib11","article-title":"Primary Hyperparathyroidism\u00a0: a tale of two cities revisited \u2013 New York and Shanghai","volume":"162\u20139","author":"Liu","year":"2013","journal-title":"Natl Publ Gr"},{"issue":"1","key":"10.1016\/j.berh.2020.101514_bib12","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1080\/10408360590886606","article-title":"Calcium-sensing receptor in normal physiology and pathophysiology","volume":"42","author":"Tfelt-hansen","year":"2005","journal-title":"Crit Rev Clin Lab Sci"},{"key":"10.1016\/j.berh.2020.101514_bib13","volume":"vols. 57\u201372","author":"Procopio","year":"2016"},{"issue":"6","key":"10.1016\/j.berh.2020.101514_bib14","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1590\/S0004-27302013000600002","article-title":"Diagnosis and management of primary hyperparathyroidism: a scientific statement from the department of bone metabolism, the Brazilian society for endocrinology and metabolism","volume":"57","author":"Bandeira","year":"2013","journal-title":"Arq Bras Endocrinol Metabol"},{"issue":"April 2010","key":"10.1016\/j.berh.2020.101514_bib15","first-page":"1653","article-title":"Skeletal effects of interventions in mild primary hyperparathyroidism: a meta-analysis","volume":"95","author":"Sankaran","year":"2015"},{"key":"10.1016\/j.berh.2020.101514_bib16","series-title":"What symptom improvement can Be expected after operation for primary hyperparathyroidism?","first-page":"2244","author":"Caron","year":"2009"},{"issue":"April","key":"10.1016\/j.berh.2020.101514_bib17","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1210\/jc.2014-3708","article-title":"Prevalence of kidney stones and vertebral fractures in primary hyperparathyroidism using imaging technology","volume":"vol. 100","author":"Cipriani","year":"2015","journal-title":"J Clin Endocrinol Metabol"},{"issue":"5","key":"10.1016\/j.berh.2020.101514_bib18","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1590\/0004-2730000003381","article-title":"Bone disease in primary hyperparathyroidism","volume":"58","author":"Bandeira","year":"2015","journal-title":"Arq Bras Endocrinol Metabol"},{"issue":"February","key":"10.1016\/j.berh.2020.101514_bib19","first-page":"2377","article-title":"Nephrolithiasis and renal calcifications in primary hyperparathyroidism","volume":"96","author":"Rejnmark","year":"2015","journal-title":"J Clin Endocrinol Metabol"},{"issue":"Suppl. 2","key":"10.1016\/j.berh.2020.101514_bib20","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1002\/jbmr.5650061415","article-title":"Clinical spectrum of primary Hyperparathyroidism\u00a0: evolution with changes in medical practice and technology","volume":"6","author":"Heath","year":"1991","journal-title":"J Bone Miner Res"},{"issue":"2","key":"10.1016\/j.berh.2020.101514_bib21","first-page":"258","article-title":"Review Article Renal manifestations of primary hyperparathyroidism","volume":"16","author":"Lila","year":"2012"},{"issue":"3","key":"10.1016\/j.berh.2020.101514_bib22","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.amjmed.2014.09.030","article-title":"Hypercalcemic Crisis\u00a0: a clinical review","volume":"128","author":"Ahmad","year":"2015","journal-title":"Am J Med"},{"key":"10.1016\/j.berh.2020.101514_bib23","series-title":"Risk of nephrolithiasis in primary hyperparathyroidism is associated with two polymorphisms of the calcium-sensing receptor gene","author":"Vezzoli","year":"2014"},{"issue":"5","key":"10.1016\/j.berh.2020.101514_bib24","first-page":"7","article-title":"Hyperparathyroidism, A forgotten cause of musculoskeletal pain","volume":"8","author":"Rubio","year":"2012"},{"key":"10.1016\/j.berh.2020.101514_bib25","series-title":"Prevalence of primary hyperparathyroidism in a referred sample of fibromyalgia patients","author":"Ferrari","year":"2014"},{"issue":"April","key":"10.1016\/j.berh.2020.101514_bib26","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1093\/rheumatology\/kep081","article-title":"An update on the epidemiology of calcium pyrophosphate dihydrate crystal deposition disease","author":"Richette","year":"2009","journal-title":"Rheumatology"},{"issue":"3","key":"10.1016\/j.berh.2020.101514_bib27","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/BF02054248","article-title":"The arthritis of hemochromatosis . A review of 25 cases with special reference to chondrocalcinosis , and a comparison with patients with primary hyperparathyroidism and controls","volume":"5","author":"Huaux","year":"1986","journal-title":"Clin Rheumatol"},{"issue":"3","key":"10.1016\/j.berh.2020.101514_bib28","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/0049-0172(92)90019-A","article-title":"Diseases associated with calcium pyrophosphate deposition disease","volume":"22","author":"Jones","year":"1992","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.berh.2020.101514_bib29","series-title":"New actions of parathyroid hormone","article-title":"The neuromuscular manifestations of primary hyperparathyroidism in humans","author":"Yamaguchi","year":"1989"},{"issue":"8","key":"10.1016\/j.berh.2020.101514_bib30","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1210\/jc.2007-0219","article-title":"Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: a prospective , randomized clinical trial","volume":"92","author":"Ambrogini","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.berh.2020.101514_bib31","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1007\/s00268-007-9006-6","article-title":"Effect of parathyroidectomy on quality of life and neuropsychological symptoms in primary hyperparathyroidism","volume":"31","author":"Weber","year":"2007","journal-title":"World J Surg"},{"issue":"6","key":"10.1016\/j.berh.2020.101514_bib32","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1210\/jc.2008-2574","article-title":"Neuropsychological features in primary Hyperparathyroidism\u00a0: a prospective study","volume":"94","author":"Walker","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"20","key":"10.1016\/j.berh.2020.101514_bib33","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1016\/j.ehj.2004.07.010","article-title":"Primary hyperparathyroidism and heart disease \u2013 a review","volume":"25","author":"Andersson","year":"2004","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.berh.2020.101514_bib34","doi-asserted-by":"crossref","first-page":"F1215","DOI":"10.1152\/ajprenal.00406.2006","article-title":"Parathyroid hormone stimulates endothelial expression of atherosclerotic parameters through protein kinase pathways","volume":"292","author":"Rashid","year":"2007","journal-title":"Am J Physiol Ren Physiol"},{"issue":"3","key":"10.1016\/j.berh.2020.101514_bib35","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1161\/01.HYP.4.3.452","article-title":"Sympathetic system function and vascular reactivity in hypercalcemic patients","volume":"4","author":"Vlachakis","year":"1982","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.berh.2020.101514_bib36","doi-asserted-by":"crossref","first-page":"49","DOI":"10.14797\/mdcj-13-2-49","article-title":"The parathyroid gland and heart disease","volume":"13","author":"Brown","year":"2017","journal-title":"Methodist Debakey Cardiovasc J"},{"issue":"6","key":"10.1016\/j.berh.2020.101514_bib37","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1111\/j.1440-1746.2007.05050.x","article-title":"Chronic pancreatitis in primary hyperparathyroidism\u00a0: comparison with alcoholic and idiopathic chronic pancreatitis","volume":"23","author":"Bhadada","year":"2008","journal-title":"J Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.berh.2020.101514_bib38","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/00000658-199509000-00017","article-title":"Clinical manifestations of primary hyperparathyroidism before and after parathyroidectomy","volume":"222","author":"Study","year":"1995","journal-title":"Ann Surg"},{"issue":"74","key":"10.1016\/j.berh.2020.101514_bib39","first-page":"197","article-title":"Primary hyperparathyroidism and the gastrointestinal tract south","volume":"2","author":"Gardner","year":"1981","journal-title":"Med J"},{"key":"10.1016\/j.berh.2020.101514_bib40","series-title":"Primary, secondary and tertiary hyperparathyroidism: diagnostic and therapeutic updates","isbn-type":"print","author":"Gasparri","year":"2015","ISBN":"https:\/\/id.crossref.org\/isbn\/9788847057586"},{"key":"10.1016\/j.berh.2020.101514_bib42","article-title":"Primary hyperparathyroidism\u00a0: review and recommendations on evaluation , diagnosis , and management. A Canadian and international consensus","volume":"1\u201319","author":"Khan","year":"2017","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.berh.2020.101514_bib43","article-title":"Parathyroid localization using 4D-computed tomography","volume":"94","author":"Bann","year":"2017","journal-title":"Ear Nose Throat"},{"issue":"1","key":"10.1016\/j.berh.2020.101514_bib44","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jss.2016.04.022","article-title":"ScienceDirect Should vitamin D deficiency be corrected before parathyroidectomy\u00a0?","volume":"204","author":"Randle","year":"2016","journal-title":"J Surg Res"},{"issue":"3","key":"10.1016\/j.berh.2020.101514_bib45","doi-asserted-by":"crossref","first-page":"R45","DOI":"10.1530\/EJE-12-0528","article-title":"Hungry bone syndrome\u00a0: still a challenge in the post-operative management of primary hyperparathyroidism\u00a0: a systematic review of the literature","volume":"168","author":"Witteveen","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"10.1016\/j.berh.2020.101514_bib48","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1210\/jc.2016-2481","article-title":"Thiazide treatment in primary hyperparathyroidism \u2013 a new indication for an old medication?","volume":"102","author":"Tsvetov","year":"2017","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Best Practice & Research Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694220300310?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694220300310?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:20:21Z","timestamp":1761499221000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521694220300310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S1521694220300310"],"URL":"https:\/\/doi.org\/10.1016\/j.berh.2020.101514","relation":{},"ISSN":["1521-6942"],"issn-type":[{"value":"1521-6942","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Primary hyperparathyroidism","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Rheumatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.berh.2020.101514","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101514"}}